Two Sigma Investments
VRDN icon

Two Sigma Investments’s Viridian Therapeutics VRDN Stock Holding History

Two Sigma Investments’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$687K Buy
+35,114
New +$1.04M ﹤0.01% 3511
2025
Q4 		– Sell
-22,011
Closed -$475K – 4458
2025
Q3 		$475K Sell
22,011
-47,966
-69% -$865K ﹤0.01% 3010
2025
Q2 		$978K Sell
69,977
-152,422
-69% -$2.07M ﹤0.01% 2265
2025
Q1 		$3M Sell
222,399
-202,138
-48% -$3.44M 0.01% 1462
2024
Q4 		$8.14M Sell
424,537
-57,599
-12% -$1.25M 0.02% 849
2024
Q3 		$11M Buy
482,136
+62,316
+15% +$1.02M 0.02% 718
2024
Q2 		$5.46M Buy
419,820
+192,966
+85% +$2.67M 0.01% 972
2024
Q1 		$3.97M Buy
+226,854
New +$4.4M 0.01% 1098
2023
Q3 		– Sell
-21,018
Closed -$500K – 3239
2023
Q2 		$500K Buy
+21,018
New +$539K ﹤0.01% 2331

Other funds holding VRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return